
Orforglipron (Research)
Non-peptide oral GLP-1 receptor agonist for advanced metabolic wellness.
Orforglipron
Orforglipron is a non-peptide, small-molecule GLP-1 receptor agonist of significant interest for its oral bioavailability profile. Unlike peptide-based GLP-1R agonists (Semaglutide, Tirzepatide) that require injection due to poor oral bioavailability, Orforglipron is a small molecule that can be administered orally and still achieve meaningful GLP-1R activation.
How It Works
Orforglipron activates the GLP-1 receptor through a binding mode distinct from peptide-based GLP-1R agonists:
• Non-Peptide GLP-1R Agonism:: Binds to the GLP-1R transmembrane domain rather than the extracellular peptide-binding domain, activating the receptor through an allosteric mechanism
• Oral Bioavailability:: Small molecule structure enables gastrointestinal absorption and systemic bioavailability following oral administration
• cAMP Signaling:: Like peptide GLP-1R agonists, activates Gs protein-coupled cAMP signaling downstream of GLP-1R, driving glucose-dependent insulin secretion, glucagon suppression, and central satiety signaling
• Appetite Suppression:: Activates central GLP-1R circuits for appetite reduction and satiety
Key Benefits
• Oral Administration:: Non-peptide structure enables oral bioavailability — no injection required
• Appetite Control:: GLP-1R activation for appetite suppression and satiety
• Weight Management:: Supports body weight reduction through GLP-1R-mediated mechanisms
• Glucose Support:: Promotes healthy glucose metabolism through GLP-1R signaling
Structural Properties
Orforglipron is a non-peptide small molecule. Purity ≥97.0%.
Quality and Purity
Verified by HPLC and mass spectrometry. Purity ≥97.0%. Each vial contains 10 mg.
Storage
Store at −20°C. Protect from moisture. Stable for 24 months.
Product Details
Storage & Handling
Store at -20°C. Protect from moisture.
Related Products

Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist for advanced metabolic support and body composition.

Cagrilintide
Long-acting amylin analogue supporting appetite regulation and metabolic balance.